drugset
drugset / Trial / NCT00946621

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

NCT00946621 ↗

Phase 1 Completed 48 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability study of Ramipril 10 mg capsules under non-fasting conditions.

Timeline

Start
2004-10
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule 10 mg —

Indications

hypertensive disorder